David Belanger
David Belanger
Kaleido Biosciences
Verified email at kaleido.com - Homepage
Title
Cited by
Cited by
Year
Thermal promotion of the cobalt catalyzed intramolecular Pauson-Khand reaction—An alternative experimental protocol for cyclopentenone synthesis
DB Belanger, DJR O'Mahony, T Livinghouse
Tetrahedron letters 39 (42), 7637-7640, 1998
1031998
Hexacarbonyldicobalt-alkyne complexes as convenient Co2 (CO) 8 surrogates in the catalytic Pauson-Khand reaction
DB Belanger, T Livinghouse
Tetrahedron letters 39 (42), 7641-7644, 1998
941998
Discovery of imidazo [1, 2-a] pyrazine-based Aurora kinase inhibitors
DB Belanger, PJ Curran, A Hruza, J Voigt, Z Meng, AK Mandal, ...
Bioorganic & medicinal chemistry letters 20 (17), 5170-5174, 2010
582010
(Alkylthio) alkynes as Addends in the Co (0) Catalyzed Intramolecular Pauson-Khand Reaction. Substituent Driven Enhancements of Annulation Efficiency and Stereoselectivity
BL Pagenkopf, DB Belanger, DJR O'Mahony, T Livinghouse
Synthesis 2000 (07), 1009-1019, 2000
442000
Imidazopyrazines as protein kinase inhibitors
L Zhao, P Curran, D Belanger, B Hamann, P Reddy, K Paruch, T Guzi, ...
US Patent App. 11/598,186, 2007
422007
On the Counterion Dependence of the Rhodium (I)-Catalysed [4+ 2] Cycloaddition-A Remarkable Accelerating Effect of the Hexafluoroantimonate Anion
DJR O'Mahony, DB Belanger, T Livinghouse
Synlett 1998 (04), 443-445, 1998
421998
Discovery of a Potent, Injectable Inhibitor of Aurora Kinases Based on the Imidazo-[1,2-a]-Pyrazine Core
T Yu, JR Tagat, AD Kerekes, RJ Doll, Y Zhang, Y Xiao, S Esposite, ...
ACS medicinal chemistry letters 1 (5), 214-218, 2010
372010
Substrate control of stereoselection in the rhodium (I) catalyzed intramolecular [4+ 2] cycloaddition reaction
DJR O'Mahony, DB Belanger, T Livinghouse
Organic & biomolecular chemistry 1 (12), 2038-2040, 2003
332003
Discovery of novel imidazo [1, 2-a] pyrazin-8-amines as Brk/PTK6 inhibitors
H Zeng, DB Belanger, PJ Curran, GW Shipps Jr, H Miao, JB Bracken, ...
Bioorganic & medicinal chemistry letters 21 (19), 5870-5875, 2011
282011
The discovery of novel tartrate-based TNF-α converting enzyme (TACE) inhibitors
KE Rosner, Z Guo, P Orth, GW Shipps Jr, DB Belanger, TY Chan, ...
Bioorganic & medicinal chemistry letters 20 (3), 1189-1193, 2010
262010
Imidazopyrazines as cyclin dependent kinase inhibitors
TJ Guzi, K Paruch, MP Dwyer, L Zhao, PJ Curran, DB Belanger, ...
US Patent 7,576,085, 2009
212009
Discovery of orally bioavailable imidazo[1,2-a]pyrazine-based Aurora kinase inhibitors
DB Belanger, MJ Williams, PJ Curran, AK Mandal, Z Meng, MP Rainka, ...
Bioorganic & medicinal chemistry letters 20 (22), 6739-6743, 2010
202010
Substituted pyrazolo [1, 5-a] pyrimidines as protein kinase inhibitors
TJ Guzi, K Paruch, MP Dwyer, MA Siddiqui, PAP Reddy, DB Belanger, ...
US Patent 7,563,798, 2009
192009
Bioisosteric approach to the discovery of imidazo[1,2-a]pyrazines as potent Aurora kinase inhibitors
Z Meng, BA Kulkarni, AD Kerekes, AK Mandal, SJ Esposite, DB Belanger, ...
Bioorganic & medicinal chemistry letters 21 (1), 592-598, 2011
182011
Synthesis and SAR studies of imidazo-[1,2-a]-pyrazine Aurora kinase inhibitors with improved off-target kinase selectivity
ME Voss, MP Rainka, M Fleming, LH Peterson, DB Belanger, MA Siddiqui, ...
Bioorganic & medicinal chemistry letters 22 (10), 3544-3549, 2012
152012
Substituted pyridines that are JNK inhibitors
DB Belanger, MA Siddiqui, PJ Curran, B Hamann, L Zhao, PAP Reddy, ...
US Patent 8,278,337, 2012
142012
Methods for inhibiting protein kinases
T Guzi, K Paruch, M Dwyer, D Parry, L Zhao, P Curran, D Belanger, ...
US Patent App. 11/598,188, 2007
142007
Novel jnk inhibitors
PAP Reddy, MA Siddiqui, PK Tadikonda, UF Mansoor, GW Shipps Jr, ...
US Patent App. 12/519,733, 2010
132010
Compounds for the treatment of inflammatory disorders
Z Guo, P Orth, Z Zhu, RD Mazzola, TY Chan, HA Vaccaro, B McKittrick, ...
US Patent 7,652,020, 2010
132010
Structure and activity relationships of tartrate-based TACE inhibitors
D Li, J Popovici-Muller, DB Belanger, J Caldwell, C Dai, M David, ...
Bioorganic & medicinal chemistry letters 20 (16), 4812-4815, 2010
112010
The system can't perform the operation now. Try again later.
Articles 1–20